Clinical trial
Implantable Neurostimulator for the Treatment of Parkinson's Disease
NCT01839396 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Implantable Neurostimulator for the Treatment of Parkinson's Disease
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 17, 2013
- Completion date
- December 5, 2022
- Enrollment
- 313 (actual)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease